Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001144204-19-012581

Options or other derivatives

  • President and CEO acquired 400,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Fardis Maria · President and CEO

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2019-03-04 Grant or award : show line 1 in the form Stock Option (right to buy) +400,000 $11.26 2019-03-04 400,000 400,000 D
Loading xslF345X03/tv515609_4.xml…